Graphite Bio, Inc.
News
Graphite Bio: Reverse Merger Leading Into Big Special Dividend And Q2 Phase 3 Trial
SeekingAlpha Graphite Bio: Reverse Merger Leading Into Big Special Dividend And Q2 Phase 3 Trial...\n more…
Short Interest in Graphite Bio, Inc. (NASDAQ:GRPH) Increases By 8.9%
Ticker Report Graphite Bio, Inc. (NASDAQ:GRPH Get Free Report) was the recipient of a large growth in short interest in the month of November. As of November 30th, there was short interest totalling...\n more…
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CSTR, GRPH
Globe Newswire NEW YORK, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...\n more…
Shareholder Alert: Ademi LLP investigates whether Graphite Bio, Inc. has obtained a Fair Price in its transaction with LENZ Therapeutics
PR Newswire Shareholder Alert: Ademi LLP investigates whether Graphite Bio, Inc. has obtained a Fair Price in its transaction with LENZ Therapeutics Shareholder Alert: Ademi LLP investigates whether Graphite...\n more…
GRPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Graphite Bio, Inc. Is Fair to Shareholders
Business Wire Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Graphite Bio, Inc. (NASDAQ: GRPH) and LENZ Therapeutics is fair to Graphite shareholders. Graphite shareholders...\n more…